Zaknoen Sara

Zaknoen Sara is listed in filings as Director at aTyr Pharma, Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including 2 public disclosures. Recent filings connect the profile to aTyr Pharma, Inc. (ATYR). The current snapshot covers public activity from May 2, 2025 to May 13, 2026. Reported amounts are shown as $47.5K to $167.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.